<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00444652</url>
  </required_header>
  <id_info>
    <org_study_id>3779</org_study_id>
    <nct_id>NCT00444652</nct_id>
  </id_info>
  <brief_title>Thromboprophylaxis and Bariatric Surgery</brief_title>
  <official_title>Thromboprophylaxis During Bariatric Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>French State</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sanofi</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is an assessment of the efficacy of three thromboprophylaxis regimens in two types
      of bariatric surgery.

      - gastric banding and gastric bypass on anti-Xa activity levels

      The study includes two groups of 150 patients scheduled for gastric banding or gastric
      bypass.

      Assessment of anti-Xa levels before and 4 hours after the injections from day 0 to 2 in order
      to determine the best prophylactic regimen allowing expected values ranged between 0.3 and
      0.5 IU / ml.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2006</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Anti-Xa activity level measured 4 hours before and after enoxaparin injection at different doses</measure>
    <time_frame>48 heures</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Microparticles</measure>
    <time_frame>day 0, 1, 9,30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thrombotic events until D30</measure>
    <time_frame>day 30</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding events</measure>
    <time_frame>day 30</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Thromboembolism</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Enoxaparin</intervention_name>
    <description>injection of enoxaparin a few time</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI over 40

          -  Gastric banding or gastric bypass

        Exclusion Criteria:

          -  Renal insufficiency

          -  Thrombopenia

          -  Long term anticoagulant treatment

          -  Pregnancy

          -  Allergy to heparin
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annick Steib, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hôpitaux Universitaire de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annick Steib, MD</last_name>
    <phone>33 3.88.11.54.10</phone>
    <email>annick.steib@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinique de l'Orangerie</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernard Vailly, MD</last_name>
      <phone>33 388567300</phone>
      <email>BVAILLY@aol.com</email>
    </contact>
    <investigator>
      <last_name>Philippe Plobner, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard Vailly, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Anesthésiologie Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martine Figier, MD</last_name>
      <phone>33 388117354</phone>
      <email>martine.figier@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Martine Figier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laboratoire d'hémostase Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lelia Grunebaum, MD</last_name>
      <phone>3 3388127528</phone>
      <email>lelia.grunebaum@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Lelia Grunebaum, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Digestive Hopital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Rohr, MD</last_name>
      <phone>33 388127223</phone>
      <email>serge.rohr@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Elisabeth Ackermann, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Serge Rohr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Générale et Endocrinienne Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <state>Alsace</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michel Vix, MD</last_name>
      <phone>33 388116883</phone>
      <email>michel.vix@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Michel Vix, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jacques Marescaux, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Département d'Anesthésiologie Hôpital de Brabois</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Etienne Junke, MD</last_name>
      <phone>33 612163929</phone>
      <email>e.junke@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Etienne Junke, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Meistelman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laboratoire d'Hémostase Hôpital de Brabois</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Lecompte, MD</last_name>
      <phone>33 383851015</phone>
      <email>thomas.lecompte@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Thomas Lecompte, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Chirurgie Digestive Hôpital de Brabois</name>
      <address>
        <city>Nancy</city>
        <state>Lorraine</state>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurent Brunaud, MD</last_name>
      <phone>33 3 83858585</phone>
      <email>i.brunaud@chu-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Laurent Brunaud, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de chirurgie générale et digestive,Hôpital Hôtel Dieu</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>karim Asehnoune, MD</last_name>
      <phone>00 332 40.08.30.05</phone>
      <email>karim.asehnoune@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Karim Asehnoune, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bertrand Rozec, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Letessier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore Avalonne, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre investigation Clinique Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal Bousquet, MD</last_name>
      <phone>33 3881176768</phone>
      <email>pascal.bousquet@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Pascal Bousquet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brandt Christian, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominique Charneau, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2007</study_first_submitted>
  <study_first_submitted_qc>March 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 8, 2007</study_first_posted>
  <last_update_submitted>June 28, 2012</last_update_submitted>
  <last_update_submitted_qc>June 28, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Thromboprophylaxis</keyword>
  <keyword>Bariatric surgery</keyword>
  <keyword>prevention of venous thromboembolism in bariatric surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thromboembolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

